These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 11399216)
21. Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Griffiths P; Gossop M; Powis B; Strang J Addiction; 1994 Mar; 89(3):301-9. PubMed ID: 8173499 [TBL] [Abstract][Full Text] [Related]
22. HIV heterosexual sexual risk from injecting drug users among HIV-seronegative noninjecting heroin users. Neaigus A; Miller M; Gyarmathy VA; Friedman SR Subst Use Misuse; 2011; 46(2-3):208-17. PubMed ID: 21303241 [TBL] [Abstract][Full Text] [Related]
23. "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. Mars SG; Bourgois P; Karandinos G; Montero F; Ciccarone D Int J Drug Policy; 2014 Mar; 25(2):257-66. PubMed ID: 24238956 [TBL] [Abstract][Full Text] [Related]
24. Flashblood: blood sharing among female injecting drug users in Tanzania. McCurdy SA; Ross MW; Williams ML; Kilonzo GP; Leshabari MT Addiction; 2010 Jun; 105(6):1062-70. PubMed ID: 20331567 [TBL] [Abstract][Full Text] [Related]
25. Comparing Injecting Risk Behaviors of Long-Term Injectors with New Injectors in Tehran, Iran. Bazrafshan MR; Noroozi M; Ghisvand H; Noroozi A; Alibeigi N; Abbasi M; Higgs P; Armoon B Subst Use Misuse; 2019; 54(2):185-190. PubMed ID: 30474470 [TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142 [TBL] [Abstract][Full Text] [Related]
27. Drugs and social exclusion in ten European cities. March JC; Oviedo-Joekes E; Romero M Eur Addict Res; 2006; 12(1):33-41. PubMed ID: 16352901 [TBL] [Abstract][Full Text] [Related]
28. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users. Gjersing L; Bretteville-Jensen AL Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019 [TBL] [Abstract][Full Text] [Related]
29. Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the Netherlands. Havinga P; van der Velden C; de Gee A; van der Poel A Harm Reduct J; 2014 Feb; 11():6. PubMed ID: 24524263 [TBL] [Abstract][Full Text] [Related]
30. Understanding the association between injecting and sexual risk behaviors of injecting drug users in Manipur and Nagaland, India. Suohu K; Humtsoe C; Saggurti N; Sabarwal S; Mahapatra B; Kermode M Harm Reduct J; 2012 Dec; 9():40. PubMed ID: 23249619 [TBL] [Abstract][Full Text] [Related]
31. Polydrug Use and HIV Risk Among People Who Inject Heroin in Tijuana, Mexico: A Latent Class Analysis. Meacham MC; Rudolph AE; Strathdee SA; Rusch ML; Brouwer KC; Patterson TL; Vera A; Rangel G; Roesch SC Subst Use Misuse; 2015; 50(10):1351-9. PubMed ID: 26444185 [TBL] [Abstract][Full Text] [Related]
32. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose. Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700 [TBL] [Abstract][Full Text] [Related]
33. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609 [TBL] [Abstract][Full Text] [Related]
34. Mental health of heroin users with differing injection drug use histories: A non-treatment sample of Mexican American young adult men. Nowotny KM; Perdue T; Cepeda A; Valdez A Drug Alcohol Depend; 2017 Dec; 181():124-131. PubMed ID: 29054031 [TBL] [Abstract][Full Text] [Related]
36. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India. Ganju D; Ramesh S; Saggurti N Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253 [TBL] [Abstract][Full Text] [Related]
37. Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks. De P; Cox J; Boivin JF; Platt RW; Jolly AM J Acquir Immune Defic Syndr; 2007 Nov; 46(3):355-61. PubMed ID: 17721398 [TBL] [Abstract][Full Text] [Related]
39. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Brugal MT; Barrio G; De LF; Regidor E; Royuela L; Suelves JM Addiction; 2002 Mar; 97(3):319-27. PubMed ID: 11964108 [TBL] [Abstract][Full Text] [Related]
40. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users]. de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]